Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Kyverna Therapeutics, Inc.

NASDAQ: KYTX · Life Sciences · 3 alerts · CIK 1994702

Share price
$4.76Close, Nov 16
Market cap
$301M
Shares outstanding
63.22MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Kyverna Therapeutics, Inc. filings on SEC EDGAR ↗

6:02 AM ET 8-K
Clinical Trial Data

Kyverna Therapeutics Clinical Trial Data

Kyverna Therapeutics announced positive one-year topline data from its KYSA-8 registrational trial for miv-cel in stiff person syndrome (SPS) and longer-term follow-up data from its KYSA-6 trial in generalized myasthenia gravis (gMG). The results demonstrated durable clinical responses and a favorable safety profile, supporting the company's plan to complete a rolling BLA submission for SPS in Q4 2026.

Earnings call
Sep 29, 2026, 10:15 AM ET

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.